T

Protara Therapeutics
D

TARA

5.42000
USD
0.10
(1.78%)
مغلق
حجم التداول
11,800
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
293,137,329
المقالات
المزيد

العنوان: Protara Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support,or PS, which includes both nutrition and fluids.